TAZYDO Trademark

Trademark Overview


On Tuesday, May 15, 2018, a trademark application was filed for TAZYDO with the United States Patent and Trademark Office. The USPTO has given the TAZYDO trademark a serial number of 87922215. The federal status of this trademark filing is REGISTERED as of Tuesday, January 1, 2019. This trademark is owned by Glaxo Group Limited. The TAZYDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
tazydo

General Information


Serial Number87922215
Word MarkTAZYDO
Filing DateTuesday, May 15, 2018
Status700 - REGISTERED
Status DateTuesday, January 1, 2019
Registration Number5642740
Registration DateTuesday, January 1, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, January 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 1, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 6, 2018ASSIGNED TO EXAMINER
Tuesday, May 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 18, 2018NEW APPLICATION ENTERED